Alexander Niessner discusses 'Anticoagulants in atrial fibrillation: Identifying high risk patients' at the 2015 ESC congress in London.
1. In atrial fibrillation patients who need treatment with NOACs, how do you identify patients at a high-risk of bleeding?
2. How do you reduce the risk?
- Electrophysiology & Arrhythmia
- Atrial Fibrillation